CEB-01 by Cebiotex for Soft Tissue Sarcoma: Likelihood of Approval

CEB-01 is under clinical development by Cebiotex and currently in Phase I for Soft Tissue Sarcoma.

Uterine Cancer Trials Made Waves This Year, Experts Say

Results from two phase III trials — NRG-GY018 and RUBY — presented earlier this year at the Society of Gynecologic Oncology (SGO) annual meeting demonstrated

November 23, 2023

New contrastive learning method could improve voice pathology detection

Voice pathology refers to a problem arising from abnormal conditions, such as dysphonia, paralysis, cysts, and even cancer, that cause abnormal vibrations in the vocal

October 17, 2023

“Weekend warrior” exercise pattern provides similar heart health benefits as regular physical activity

People who find it difficult to find time to exercise during a busy work week may concentrate their moderate-to-vigorous physical activity to one to two

July 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.